Coronavirus Lounge
- Thread starter JR5
- Start date
1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea - PubMed
The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent...
pubmed.ncbi.nlm.nih.gov
1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea
The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent risks of overall cancers 1 year after COVID-19 vaccination. Data from 8,407,849 individuals between 2021 and 2023 were obtained from the Korean National Health Insurance database. The participants were categorized into two groups based on their COVID-19 vaccination status. The risks for overall cancer were assessed using multivariable Cox proportional hazards models, and data were expressed as hazard ratios (HRs) and 95% confidence intervals (CIs). The HRs of thyroid (HR, 1.351; 95% CI, 1.206-1.514), gastric (HR, 1.335; 95% CI, 1.130-1.576), colorectal (HR, 1.283; 95% CI, 1.122-1.468), lung (HR, 1.533; 95% CI, 1.254-1.874), breast (HR, 1.197; 95% CI, 1.069-1.340), and prostate (HR, 1.687; 95% CI, 1.348-2.111) cancers significantly increased at 1 year post-vaccination. In terms of vaccine type, cDNA vaccines were associated with the increased risks of thyroid, gastric, colorectal, lung, and prostate cancers; mRNA vaccines were linked to the increased risks of thyroid, colorectal, lung, and breast cancers; and heterologous vaccination was related to the increased risks of thyroid and breast cancers. Given the observed associations between COVID-19 vaccination and cancer incidence by age, sex, and vaccine type, further research is needed to determine whether specific vaccination strategies may be optimal for populations in need of COVID-19 vaccination.
Hyperinflamation also seems to be connected to covid injections:
Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review - PMC
The current SARS-CoV-2 pandemic diffused worldwide has encouraged the rapid development of vaccines to counter the spread of the virus. At present in Italy, 75.01% of the population completed the vaccination course (AIFA.gov.it) and very few adverse ...
pmc.ncbi.nlm.nih.gov
They gave Anankira to some of them to cure from inflamation.
Inflamation is considered an hallmark of cancer:
Treating Cancer by Reducing Tumor-Related Inflammation
Researchers are exploring whether people with cancer benefit from treatments that reduce inflammation around tumors. Some studies show promising results.
www.cancer.gov
1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea - PubMed
The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent...
1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea
The oncogenic potential of SARS-CoV-2 has been hypothetically proposed, but real-world data on COVID-19 infection and vaccination are insufficient. Therefore, this large-scale population-based retrospective study in Seoul, South Korea, aimed to estimate the cumulative incidences and subsequent risks of overall cancers 1 year after COVID-19 vaccination. Data from 8,407,849 individuals between 2021 and 2023 were obtained from the Korean National Health Insurance database. The participants were categorized into two groups based on their COVID-19 vaccination status. The risks for overall cancer were assessed using multivariable Cox proportional hazards models, and data were expressed as hazard ratios (HRs) and 95% confidence intervals (CIs). The HRs of thyroid (HR, 1.351; 95% CI, 1.206-1.514), gastric (HR, 1.335; 95% CI, 1.130-1.576), colorectal (HR, 1.283; 95% CI, 1.122-1.468), lung (HR, 1.533; 95% CI, 1.254-1.874), breast (HR, 1.197; 95% CI, 1.069-1.340), and prostate (HR, 1.687; 95% CI, 1.348-2.111) cancers significantly increased at 1 year post-vaccination. In terms of vaccine type, cDNA vaccines were associated with the increased risks of thyroid, gastric, colorectal, lung, and prostate cancers; mRNA vaccines were linked to the increased risks of thyroid, colorectal, lung, and breast cancers; and heterologous vaccination was related to the increased risks of thyroid and breast cancers. Given the observed associations between COVID-19 vaccination and cancer incidence by age, sex, and vaccine type, further research is needed to determine whether specific vaccination strategies may be optimal for populations in need of COVID-19 vaccination.
Hyperinflamation also seems to be connected to covid injections:
Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review - PMC
The current SARS-CoV-2 pandemic diffused worldwide has encouraged the rapid development of vaccines to counter the spread of the virus. At present in Italy, 75.01% of the population completed the vaccination course (AIFA.gov.it) and very few adverse ...
They gave Anankira to some of them to cure from inflamation.
Inflamation is considered an hallmark of cancer:
Treating Cancer by Reducing Tumor-Related Inflammation
Researchers are exploring whether people with cancer benefit from treatments that reduce inflammation around tumors. Some studies show promising results.
What do you mean? The experimental mutagens clearly increase cancer survival rates, a timely blessing as cancer rates have risen since their introduction.
"I know a sonographer who's been a sonographer for 40 years, and she reads ultrasounds. So she can read ultrasounds, and she can tell the mother, 'Oh, you got Pfizer, you got Moderna.' And if they're like, well, no, I didn't get the vaccine. Well, the placenta has these characteristics of this shot, and the dad is responsible for the, placenta health. And so the placenta will carry dad's DNA. So, if it's there, it's from dad. So even if the mother didn't receive the shot, but the dad did, it still will affect the baby... That mRNA Protein. It's in the sperm also...
"[And] the babies are still being born dead, and we're in 2025. And so mothers aren't necessarily receiving the COVID vaccines anymore. They are getting cov— They're getting vaccinated for TDAP, the flu. And then, like, RSV is a newer one. When they go to their doctor, they push all of these. So whether it's Covid or it's these new ones, I— I'm not sure. But the babies are still dying. And it's. Every time I go to work, there's a dead baby. And that, never should be normal.
"And I have asked many nurses— Are they okay with this? Yep. And they all say, I appreciate what you're doing. I believe you, but I can't lose my job."